Exploring prognosis and therapeutic strategies for HBV-HCC patients based on disulfidptosis-related genes

Exploring prognosis and therapeutic strategies for HBV-HCC patients based on disulfidptosis-related genes

BackgroundHepatocellular carcinoma (HCC) accounts for over 80% of primary liver cancers and is the third leading cause of cancer-related deaths worldwide. Hepatitis B virus (HBV) infection is the primary etiological factor. Disulfidptosis is a newly discovered form of regulated cell death. This stud...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chuankuo Zhang, Xing Zhang, Shengjie Dai, Wenjun Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Genetics
Subjects:	disulfidptosis hepatitis B virus hepatocellular carcinoma immunotherapy prognosis model
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2024.1522484/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
by: Chiao-Ling Li, et al.
Published: (2025-01-01)

Disulfidptosis-related immune patterns predict prognosis and characterize the tumor microenvironment in oral squamous cell carcinoma
by: Xuechen Wu, et al.
Published: (2025-02-01)

Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC
by: Haotian Qin, et al.
Published: (2025-01-01)

Ultrasound-guided percutaneous microwave ablation for metabolic-associated fatty liver disease-related hepatocellular carcinoma (HCC) versus hepatitis virus B-related HCC: a propensity score matching study
by: Yannan Qiao, et al.
Published: (2024-12-01)

Heterogeneity in polyamine metabolism dictates prognosis and immune checkpoint blockade response in hepatocellular carcinoma
by: Jianyan Pan, et al.
Published: (2025-02-01)

Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation
by: Tao Shen, et al.
Published: (2025-02-01)

Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression
by: Liqin Ruan, et al.
Published: (2025-02-01)

Machine Learning-based Prediction of HBV-related Hepatocellular Carcinoma and Detection of Key Candidate Biomarkers
by: Zeynep KUCUKAKCALI, et al.
Published: (2022-09-01)

Transcriptomic and metabolomic analyses reveal the spatial role of carnitine metabolism in the progression of hepatitis B virus cirrhosis to hepatocellular carcinoma
by: Pengxiang Gao, et al.
Published: (2024-12-01)

Identification of disulfidptosis-related subtypes in gastric cancer and GAMT is a key gene during disulfidptosis
by: Wenxue Wu, et al.
Published: (2025-01-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Pan-Cancer Analysis of Disulfidptosis-Related Genes Affecting Prognosis and Tumor Microenvironment
by: Jingyang SUN, et al.
Published: (2025-01-01)

HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection
by: Yasmin Badshah, et al.
Published: (2025-01-01)

Risk factors of development of hepatocellular carcinoma
by: V. T. Ivashkin, et al.
Published: (2009-02-01)

PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
by: He Z, et al.
Published: (2025-01-01)

The sex differences in diseases progression and prognosis among persons with HIV and HBV coinfection
by: Rongrong Yang, et al.
Published: (2025-02-01)

MicroRNA-3145 as a potential therapeutic target for hepatitis B virus: inhibition of viral replication via downregulation of HBS and HBX
by: Amrizal Muchtar, et al.
Published: (2025-01-01)

Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis
by: Abdullah A. Awadh, et al.
Published: (2024-12-01)

Comprehensive analysis of disulfidptosis-related genes and the immune microenvironment in heart failure
by: Linna Zhao, et al.
Published: (2025-01-01)

Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study
by: Bingren Hu, et al.
Published: (2024-12-01)

Magnetic resonance imaging radiomics based on artificial intelligence is helpful to evaluate the prognosis of single hepatocellular carcinoma
by: Jing Zhou, et al.
Published: (2025-01-01)

Disulfidptosis-related gene SLC3A2: a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma
by: Xinyi Zhang, et al.
Published: (2025-01-01)

Baseline FIB‐4 May Be a Risk Factor of Recurrence After SBRT in Patients With HBV‐Related Small HCC
by: Zhan Zeng, et al.
Published: (2025-01-01)

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
by: Meng Wu, et al.
Published: (2025-02-01)

Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature
by: Yong Huang, et al.
Published: (2025-01-01)

Radiomics-based biomarker for PD-1 status and prognosis analysis in patients with HCC
by: Gulizaina Hapaer, et al.
Published: (2025-01-01)

A machine learning model and identification of immune infiltration for chronic obstructive pulmonary disease based on disulfidptosis-related genes
by: Sijun Li, et al.
Published: (2025-01-01)

Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning
by: Shuxian Pan, et al.
Published: (2025-01-01)

Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
by: Ye Ji Jun, et al.
Published: (2024-11-01)

Evaluation of the role of unconventional prefoldin RPB5 interactor (URI1) in hepatitis B virus infection
by: Karolína Štaflová, et al.
Published: (2025-01-01)

Bayesian Analysis of Complex Mutations in HBV, HCV, and HIV Studies
by: Bing Liu, et al.
Published: (2019-09-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Expression and clinical significance of disulfidptosis-related LncRNA in gastric cancer
by: CHU Yudan, SUN Haidong, CUI Ran, ZHENG Hong
Published: (2024-09-01)

Disulfidptosis as a key regulator of glioblastoma progression and immune cell impairment
by: Yifu Shu, et al.
Published: (2025-01-01)

Identification of a novel disulfidptosis-related gene signature in osteoarthritis using bioinformatics analysis and experimental validation
by: Mingjie Wei, et al.
Published: (2025-01-01)

Bioinformation study of immune microenvironment characteristics of disulfidptosis-related subtypes in ovarian cancer and prognostic model construction
by: Ying Zhou, et al.
Published: (2025-01-01)

Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study
by: Chen S, et al.
Published: (2025-02-01)

Single-cell mitophagy patterns within the tumor microenvironment modulate intercellular communication, impacting the progression and prognosis of hepatocellular carcinoma
by: Zhengyan Li, et al.
Published: (2025-01-01)

Quantitative dynamic evaluation HBsAg in blood in comparison to viral load level in patients with chronic HBV-monoinfection
by: K. R. Dudina, et al.
Published: (2011-06-01)

Identifying disulfidptosis-related biomarkers in epilepsy based on integrated bioinformatics and experimental analyses
by: Sijun Li, et al.
Published: (2025-02-01)